ROBERT AZELBY
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
EXECUTIVE OFFICER, DIRECTOR
SUSAN ALTSCHULLER, AOIFE BRENNAN, JAMES BUCHER, ALEXANDER (BO) COMBO, KIMBERLEE DRAPKIN, JUDITH DUNN, DAVID-ALEXANDRE GROS, ERIN LAVELLE, ANDREW LEVIN, VALERIE MORISSET, LEONE PATTERSON, LIAM RATCLIFFE, ADAM ROSENBERG, HARALD STOCK, SIMON TATE, STEPHEN THOMAS, JULIO VEGA, DOUGLAS WILLIAMS, PERRIN WILSON
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2024-02-13
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-05-21
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$25,000,001 - $100,000,000
Equity
2017-09-26
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$5,000,001 - $25,000,000
Equity
2015-06-29
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$5,000,001 - $25,000,000
Equity
2015-06-29

